Literature DB >> 25904686

Increased oxidative stress is related to disease severity in the ALS motor cortex: A PET study.

Masamichi Ikawa1, Hidehiko Okazawa1, Tetsuya Tsujikawa1, Akiko Matsunaga1, Osamu Yamamura1, Tetsuya Mori1, Tadanori Hamano1, Yasushi Kiyono1, Yasunari Nakamoto1, Makoto Yoneda2.   

Abstract

OBJECTIVE: To investigate cerebral oxidative stress based on an over-reductive state caused by mitochondrial dysfunction and its relationship to disease severity in patients with amyotrophic lateral sclerosis (ALS) using PET with [(62)Cu]diacetyl-bis(N(4)-methylthiosemicarbazone) ((62)Cu-ATSM).
METHODS: Twelve patients with ALS and 9 age-matched healthy controls underwent a 20-minute dynamic brain PET scan after (62)Cu-ATSM injection. The standardized uptake value (SUV) images obtained from the last 10 minutes of frames were normalized by the global mean (nSUV). Regional (62)Cu-ATSM retention in the nSUV images was compared between groups using statistical parametric mapping (SPM) and region of interest (ROI) analysis. Secondary analyses evaluated the correlations between regional nSUVs and the clinical characteristics of the participants.
RESULTS: In SPM mapping, patients with ALS showed a significantly greater accumulation of (62)Cu-ATSM compared to controls in the bilateral cortices around the central sulcus, including the motor cortex, and the right superior parietal lobule. ROI analysis also revealed significantly greater nSUVs in patients than controls in these regions. Increases in nSUV for these regions were associated with decreases in the revised ALS Functional Rating Scale score, suggesting a good correlation with the severity of ALS. In controls, age was correlated with nSUV for the bilateral cortices around the central sulcus, although this correlation was not observed in patients with ALS.
CONCLUSIONS: (62)Cu-ATSM PET imaging demonstrated increased oxidative stress based on an over-reductive state, primarily in the motor cortex, in patients with ALS. The magnitude of oxidative stress correlated well with clinical severity, indicating that it may be associated with neurodegenerative changes in ALS.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25904686     DOI: 10.1212/WNL.0000000000001588

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

Review 1.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

Review 2.  Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.

Authors:  Stefanie M A Willekens; Donatienne Van Weehaeghe; Philip Van Damme; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-08       Impact factor: 9.236

Review 3.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

4.  Amide signal intensities may be reduced in the motor cortex and the corticospinal tract of ALS patients.

Authors:  Zhuozhi Dai; Sanjay Kalra; Dennell Mah; Peter Seres; Hongfu Sun; Renhua Wu; Alan H Wilman
Journal:  Eur Radiol       Date:  2020-09-09       Impact factor: 5.315

5.  Flow-metabolism uncoupling in the cervical spinal cord of ALS patients.

Authors:  Toru Yamashita; Tetsuhiro Hatakeyama; Kota Sato; Yusuke Fukui; Nozomi Hishikawa; Yasuyuki Ohta; Yoshihiro Nishiyama; Nobuyuki Kawai; Takashi Tamiya; Koji Abe
Journal:  Neurol Sci       Date:  2017-01-24       Impact factor: 3.307

6.  CuII (atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease.

Authors:  Adam Southon; Kathryn Szostak; Karla M Acevedo; Krista A Dent; Irene Volitakis; Abdel A Belaidi; Kevin J Barnham; Peter J Crouch; Scott Ayton; Paul S Donnelly; Ashley I Bush
Journal:  Br J Pharmacol       Date:  2020-01-14       Impact factor: 8.739

7.  Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD.

Authors:  Jared R Williams; Emiliano Trias; Pamela R Beilby; Nathan I Lopez; Edwin M Labut; C Samuel Bradford; Blaine R Roberts; Erin J McAllum; Peter J Crouch; Timothy W Rhoads; Cliff Pereira; Marjatta Son; Jeffrey L Elliott; Maria Clara Franco; Alvaro G Estévez; Luis Barbeito; Joseph S Beckman
Journal:  Neurobiol Dis       Date:  2016-01-27       Impact factor: 5.996

8.  Renal function in amyotrophic lateral sclerosis patients on long-term treatment with edaravone.

Authors:  Asako Kakimoto; Masatoshi Ishizaki; Hidetsugu Ueyama; Yasushi Maeda; Mitsuharu Ueda
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

Review 9.  Intersection between Redox Homeostasis and Autophagy: Valuable Insights into Neurodegeneration.

Authors:  Hyungsun Park; Jongyoon Kim; Chihoon Shin; Seongju Lee
Journal:  Antioxidants (Basel)       Date:  2021-04-28

Review 10.  Immune-microbiome interplay and its implications in neurodegenerative disorders.

Authors:  Ankit Uniyal; Vineeta Tiwari; Mousmi Rani; Vinod Tiwari
Journal:  Metab Brain Dis       Date:  2021-08-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.